NASDAQ:ISEE - IVERIC bio News Headlines

$1.09

-0.01 (-0.91 %)

(As of 08/16/2019 04:00 PM ET)

Add

Today's Range

$1.09

Now: $1.09▼

$1.14

50-Day Range

$1.11

MA: $1.21▼

$1.30

52-Week Range

$1.02

Now: $1.09▼

$2.60

Volume24,700 shs

Average Volume76,428 shs

Market Capitalization$45.30 million

P/E RatioN/A

Dividend YieldN/A

Beta1.17

Source:

Date	Headline
	IVERIC bio (ISEE) Presents At Wedbush PacGrow Healthcare Conference - Slideshow seekingalpha.com - August 15 at 3:18 PM
	IVERIC bio to Present at the Wedbush PacGrow Healthcare Conference finance.yahoo.com - August 7 at 3:19 PM
	IVERIC bio (NASDAQ:ISEE) Announces Quarterly Earnings Results www.americanbankingnews.com - August 3 at 10:45 PM
	IVERIC bio's (ISEE) Q2 Loss Narrows, Gene Therapy in Focus www.nasdaq.com - August 2 at 9:47 PM
	Iveric Bio, Inc. (ISEE) CEO Glenn Sblendorio on Q2 2019 Results - Earnings Call Transcript seekingalpha.com - August 2 at 3:17 PM
	IVERIC bio's (ISEE) Q2 Loss Narrows, Gene Therapy in Focus finance.yahoo.com - August 2 at 3:17 PM
	IVERIC bio (ISEE) Scheduled to Post Quarterly Earnings on Thursday www.americanbankingnews.com - July 26 at 9:33 AM
	IVERIC bio to Report Second Quarter 2019 Financial Results and Host Conference Call on Thursday, August 1, 2019 finance.yahoo.com - July 25 at 8:07 AM
	IVERIC bio Announces Successful Advancement of LCA10 Minigene Program and Expansion of Orphan Gene Therapy Portfolio with USH2A-Related Inherited Retinal Diseases Program finance.yahoo.com - July 24 at 12:46 AM

This page was last updated on 8/17/2019 by MarketBeat.com Staff

Headlines